About K2bio
K2bio is a company based in Houston (United States) founded in 2021 by Andrew Strong. K2bio has raised $615.52 thousand across 1 funding round. K2bio offers products and services including CRO Services, Lab Space, Vivarium Services, and Analytical Development. K2bio operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter Houston, United States
- Founders Andrew Strong
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name K2 Biolabs, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$615.52 K (USD)
in 1 rounds
-
Latest Funding Round
$615.52 K (USD), Seed
Aug 01, 2023
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of K2bio
K2bio offers a comprehensive portfolio of products and services, including CRO Services, Lab Space, Vivarium Services, and Analytical Development.
Provides full GLP and non-GLP studies for preclinical development.
Offers ultra-modern bio-accelerator for independent research execution.
Manages on-site vivarium for in vivo studies and client support.
Supports process controls and product assessments per cGMP standards.
Funding Insights of K2bio
K2bio has successfully raised a total of $615.52K through 1 strategic funding round. The most recent funding activity was a Seed round of $615.52 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by K2bio
Investment portfolio details for K2bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - K2bio
Detailed financials for K2bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
K2bio Comparisons
Peer comparison for K2bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of K2bio
K2bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services for small molecules are provided.
|
|
| Locked | Locked | Locked |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Generic drugs and clinical research services are provided globally.
|
|
| Locked | Locked | Locked |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
|
| Locked | Locked | Locked |
AI powered scientific data management and workflow automation solutions
|
Detailed competitors of K2bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on K2bio
Complete news archive for K2bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about K2bio
K2bio was founded in 2021 and raised its 1st funding round 2 years after it was founded.
K2bio is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
K2bio is a funded company, having raised a total of $615.52K across 1 funding round to date.
K2bio was founded in 2021 in Houston, United States. Operations are conducted as a contract research organization in the biotech sector. Research site services and consulting are offered to support client projects. The company is led by co-founder Andrew Strong. Focus is placed on delivering specialized research and advisory functions within the life sciences field.
K2bio offers CRO Services, Lab Space, Vivarium Services, and Analytical Development.